🇺🇸 ARMLUPEG in United States

FDA authorised ARMLUPEG on 28 November 2025

Marketing authorisation

FDA — authorised 28 November 2025

  • Application: BLA761212
  • Marketing authorisation holder: LUPIN LTD
  • Local brand name: ARMLUPEG
  • Indication: INJECTION — SOLUTION
  • Status: approved

Read official source →

ARMLUPEG in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in United States

Frequently asked questions

Is ARMLUPEG approved in United States?

Yes. FDA authorised it on 28 November 2025.

Who is the marketing authorisation holder for ARMLUPEG in United States?

LUPIN LTD holds the US marketing authorisation.